Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2026-02-19 @ 8:00 PM
Study NCT ID:
NCT01908192
Status:
TERMINATED
Last Update Posted:
2024-05-09
First Post:
2013-07-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®
Sponsor:
SyneuRx International (Taiwan) Corp
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SNR-01-NaBen
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None